<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD01730000_1</Organism_ID>
  <Organism>Rat</Organism>
  <Organism_Latin>Rattus norvegicus</Organism_Latin>
  <UniProt_ID>P42260</UniProt_ID>
  <Seq_Length>908</Seq_Length>
  <Molecule_Weight>102470</Molecule_Weight>
  <KEGG_ID>rno:54257</KEGG_ID>
  <Orthology_ID>K05202</Orthology_ID>
  <Function_Summary>Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. May be involved in the transmission of light information from the retina to the hypothalamus. Modulates cell surface expression of NETO2 (By similarity).</Function_Summary>
  <Pfam_ID>PF01094:ANF_receptor@@PF00060:Lig_chan@@PF10613:Lig_chan-Glu_bd</Pfam_ID>
  <Allosteric_Activator_Count>3</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>72</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Glutamate receptor 6</Alias>
      <Alias>GluK2</Alias>
      <Alias>GluR6</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.</Detail>
      <Keyword>Ubiquitin protein ligase binding</Keyword>
      <Ontology_ID>GO:0031625</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of facilitated diffusion of an ion (by an energy-independent process) by passage through a transmembrane aqueous pore or channel without evidence for a carrier-mediated mechanism.</Detail>
      <Keyword>Ion channel activity</Keyword>
      <Ontology_ID>GO:0005216</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the transmembrane transfer of an ion by a channel that opens when extracellular glutamate has been bound by the channel complex or one of its constituent parts.</Detail>
      <Keyword>Extracellular-glutamate-gated ion channel activity</Keyword>
      <Ontology_ID>GO:0005234</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>An ionotropic glutamate receptor activity that exhibits fast gating by glutamate, acts by opening a cation channel permeable to sodium and potassium, and for which kainate is an agonist.</Detail>
      <Keyword>Kainate selective glutamate receptor activity</Keyword>
      <Ontology_ID>GO:0015277</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a ubiquitin conjugating enzyme, any of the E2 proteins.</Detail>
      <Keyword>Ubiquitin conjugating enzyme binding</Keyword>
      <Ontology_ID>GO:0031624</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Combining with an extracellular or intracellular messenger to initiate a change in cell activity.</Detail>
      <Keyword>Receptor activity</Keyword>
      <Ontology_ID>GO:0004872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a PDZ domain of a protein, a domain found in diverse signaling proteins.</Detail>
      <Keyword>PDZ domain binding</Keyword>
      <Ontology_ID>GO:0030165</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein to form a homodimer.</Detail>
      <Keyword>Protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0042803</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Protein which forms or is a component of a ligand-gated channel. Ligand-gated channels are transmembrane ion channels whose permeability is increased by the binding of a specific ligand, such as neurotransmitters, ionositol triphosphates, and cyclic nucleotides.</Detail>
      <Keyword>Ligand-gated ion channel</Keyword>
      <Ontology_ID>KW-1071</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>567</Position>
      <Original>Ile</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>571</Position>
      <Original>Tyr</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>621</Position>
      <Original>Gln</Original>
      <Variation>Arg</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The receptor metabolic process that results in grouping of a set of receptors at a cellular location, often to amplify the sensitivity of a signaling response.</Detail>
      <Keyword>Receptor clustering</Keyword>
      <Ontology_ID>GO:0043113</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of glutamatergic synaptic transmission, the process of communication from a neuron to another neuron across a synapse using the neurotransmitter glutamate.</Detail>
      <Keyword>Negative regulation of synaptic transmission, glutamatergic</Keyword>
      <Ontology_ID>GO:0051967</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of signal transduction mediated by the JNK cascade.</Detail>
      <Keyword>Regulation of JNK cascade</Keyword>
      <Ontology_ID>GO:0046328</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of apoptosis in neurons, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.</Detail>
      <Keyword>Neuron apoptosis</Keyword>
      <Ontology_ID>GO:0051402</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of substances (such as macromolecules, small molecules, ions) into, out of or within a cell, or between cells, or within a multicellular organism by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Transport</Keyword>
      <Ontology_ID>GO:0006810</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of charged atoms or small charged molecules into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Ion transport</Keyword>
      <Ontology_ID>GO:0006811</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MKIISPVLSNLVFSRSIKVLLCLLWIGYSQGTTHVLRFGGIFEYVESGPMGAEELAFRFAVNTINRNRTLLPNTTLTYDTQKINLYDSFEASKKACDQLSLGVAAIFGPSHSSSANAVQSICNALGVPHIQTRWKHQVSDNKDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDSTGLIRLQELIKAPSRYNLRLKIRQLPADTKDAKPLLKEMKRGKEFHVIFDCSHEMAAGILKQALAMGMMTEYYHYIFTTLDLFALDVEPYRYSGVNMTGFRILNTENTQVSSIIEKWSMERLQAPPKPDSGLLDGFMTTDAALMYDAVHVVSVAVQQFPQMTVSSLQCNRHKPWRFGTRFMSLIKEAHWEGLTGRITFNKTNGLRTDFDLDVISLKEEGLEKIGTWDPASGLNMTESQKGKPANITDSLSNRSLIVTTILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEIRLVEDGKYGAQDDVNGQWNGMVRELIDHKADLAVAPLAITYVREKVIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYILLAYLGVSCVLFVIARFSPYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLVKSNEEGIQRVLTSDYAFLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEESKEASALGVQNIGGIFIVLAAGLVLSVFVAVGEFLYKSKKNAQLEKRSFCSAMVEELRMSLKCQRRLKHKPQAPVIVKTEEVINMHTFNDRRLPGKETMA</Protein_Seq>
    <DNA_Seq>GGGCTCGCAAGGGCTTCGCAGGCTGGACATTGTGCTTGCTGGATTTTTCCCGGATGCTCCCGGACTAACATGGATGTCCCACCATCCCTTGCAGTGGAAGCTTGCTCCTTGGCGCAGTGAGAGTGAAGAACATGCAGCGACTGCTAATGGGTTTGGGAAGCGGAGACTCCTTCCTCTTTCTGTGACCATGCCGTGATTGTGTCTGCGGCCACTACTCCACGCATCTTCCTTCTCGTCCAAGCCCGGAGCCTAACGCTAGATCGGGGAAGTGGGTGCCGCGCGCGCAGGCACGGAAACATCATGAAGATTATTTCCCCAGTTTTAAGTAATCTAGTCTTCAGTCGCTCCATTAAAGTCCTGCTCTGCTTATTGTGGATCGGATATTCGCAAGGAACCACACATGTGTTAAGATTCGGTGGTATATTTGAATATGTGGAATCTGGCCCCATGGGAGCAGAAGAACTTGCATTCAGATTTGCTGTGAATACCATCAACAGAAACAGGACTTTGCTGCCCAACACCACTTTAACTTATGATACTCAGAAGATCAATCTCTATGACAGTTTTGAAGCATCTAAGAAAGCTTGTGATCAGCTGTCTCTTGGGGTGGCTGCTATCTTCGGTCCTTCACACAGTTCATCAGCCAATGCTGTGCAGTCCATCTGCAATGCTCTGGGGGTTCCCCACATACAGACCCGCTGGAAGCACCAGGTGTCAGACAACAAGGATTCCTTCTACGTCAGTCTCTACCCAGACTTCTCTTCCCTGAGCCGCGCCATCTTGGATTTGGTGCAGTTTTTTAAGTGGAAAACTGTCACAGTTGTGTATGACGACAGCACTGGTCTCATTCGCTTGCAAGAGCTCATCAAAGCTCCATCGAGGTACAATCTTCGACTTAAAATTCGTCAGCTGCCAGCTGATACCAAAGATGCAAAACCTTTGCTGAAGGAGATGAAAAGAGGCAAGGAGTTCCACGTGATCTTCGACTGCAGCCATGAGATGGCAGCAGGCATTTTAAAACAGGCATTAGCTATGGGAATGATGACAGAATACTATCACTATATATTTACAACTCTGGACCTCTTTGCTCTTGACGTGGAGCCCTACAGATACAGTGGCGTAAATATGACAGGGTTCAGGATACTAAATACAGAGAATACCCAAGTCTCCTCCATCATCGAAAAGTGGTCTATGGAACGGTTACAGGCGCCTCCAAAACCTGACTCAGGTTTGCTGGATGGATTTATGACGACTGATGCTGCTCTGATGTATGATGCAGTGCACGTTGTGTCTGTGGCTGTCCAACAGTTTCCCCAGATGACAGTCAGCTCCTTGCAATGCAATCGACACAAACCCTGGCGCTTTGGGACCCGCTTCATGAGTCTAATTAAAGAGGCTCACTGGGAAGGTCTCACAGGCAGAATAACATTTAACAAAACCAATGGATTACGGACAGATTTTGATTTGGATGTGATCAGTCTCAAGGAAGAAGGTCTGGAGAAGATTGGAACTTGGGATCCAGCCAGTGGCCTGAATATGACAGAAAGTCAGAAAGGAAAGCCAGCAAATATCACAGACTCATTGTCTAATCGTTCTTTGATTGTTACCACCATTTTGGAAGAACCGTATGTTCTGTTTAAGAAGTCTGACAAACCACTCTATGGGAATGATCGATTTGAAGGCTACTGTATTGATCTCCTACGAGAGTTATCTACAATCCTTGGCTTTACATATGAGATTAGGCTTGTGGAGGATGGGAAATATGGAGCCCAGGATGATGTGAACGGACAATGGAATGGAATGGTTCGTGAACTAATCGATCATAAAGCTGACCTTGCAGTTGCTCCACTGGCTATAACCTATGTTCGTGAGAAGGTCATCGACTTTTCAAAGCCGTTTATGACACTTGGAATAAGTATTTTGTACCGCAAGCCCAATGGTACAAACCCAGGCGTCTTCTCCTTCCTGAATCCTCTCTCCCCTGATATCTGGATGTATGTTCTGCTGGCTTGCTTGGGTGTCAGTTGTGTGCTCTTTGTCATAGCCAGGTTTAGTCCCTATGAGTGGTATAACCCACACCCTTGCAACCCTGACTCAGACGTGGTGGAAAACAATTTTACCTTGCTAAATAGTTTCTGGTTTGGAGTTGGAGCTCTCATGCGGCAAGGTTCTGAGCTCATGCCCAAAGCACTCTCCACCAGGATAGTGGGAGGCATTTGGTGGTTTTTCACACTTATCATCATTTCTTCGTATACCGCTAACCTAGCCGCCTTTCTGACTGTGGAACGCATGGAGTCGCCCATTGACTCTGCTGACGATTTAGCTAAGCAAACCAAGATAGAGTATGGAGCAGTGGAGGACGGCGCAACCATGACGTTTTTTAAGAAATCAAAAATTTCAACGTATGATAAAATGTGGGCGTTTATGAGCAGCAGGAGACAGTCTGTGCTTGTCAAAAGCAATGAGGAAGGGATCCAACGAGTCCTCACCTCGGATTATGCTTTCTTAATGGAGTCAACAACCATCGAGTTTGTTACACAGCGGAACTGTAACCTCACGCAGATTGGCGGCCTTATAGACTCCAAAGGCTATGGCGTTGGCACTCCTATGGGCTCTCCATATCGAGACAAAATCACCATAGCAATTCTTCAGCTGCAGGAGGAAGGCAAGCTGCACATGATGAAGGAGAAATGGTGGCGGGGCAATGGCTGCCCAGAGGAGGAGAGCAAAGAGGCCAGTGCTCTGGGGGTGCAGAATATTGGTGGTATCTTCATTGTCCTGGCAGCCGGCTTGGTGCTCTCAGTTTTTGTGGCAGTGGGAGAGTTTTTATACAAATCCAAAAAAAACGCTCAATTGGAAAAGAGGTCCTTCTGTAGCGCTATGGTGGAAGAGCTGAGAATGTCCCTGAAGTGCCAGCGTCGGCTCAAACATAAGCCACAGGCCCCAGTTATTGTGAAAACAGAAGAAGTTATCAACATGCACACATTTAACGACAGAAGGTTGCCAGGTAAAGAAACCATGGCATGAAGCTGGGAGGCCAATCACCCAAGCACAAACTGTCGTCTTTTTTTTTTTTTTTTCCAAACAATTTAGCGAGAATGTTTCCTGTGGAAATATGCAACCTGTGCAAAATAAAATGAGTTACCTCATGCCGCTGTGTCTATGAACTAGAGACTCTGTGATCTAAGCAGTTTCAGTGATCAGACTTGATTTACAAGCACCGTGGATCAACCAAGTTACACGGGGTTACACTGTTTATCATAGGTTCCTCCCTTCCTTTGAGTGAATGTTACATGCAAATGTTGTGGCTGGTTTCAAATGCAGTCCAGGGAGAAACTGCTGGTTCCTTCTGAAGCTCAGCTGTCGTCAGGAGATGGAATGCCGGTGCCCAAAAGGGTAACCAATAAAAATGCCATAAAAATTTTAAAAAAATGCGTGAGATCGGCAAAAATTATAGTGTTACAAGAAACAGTACAGTCCCATGGTCACCAACACAATAGAGGTGATAATGTTACTAGCCCCCAATACTCAGTAAAATCGTCATCTGAATAGATAATATGTGTTCATAGAATGTGAAAAAAAATGTAATGCGAGACACACCAGTATCAATAGAAGTGGAACTGAAGGCAGAACATCATCAGTTACTTTTCTTTTTCAATAGTCTGTGTCATGGATTGTGATATAGATGGCAATTATCAAGCCAATAATTTTTTTTCTGAAAATACCTATGGCAAATATTTTAATAGGCAACTTGCTCCCACAAATCCCTACTCTAACCTCCCCCAGAAATATAAAAGGAACCATTGGTTTAGAGATTGGTATGTAAGAGATGATGTTTTGCAAGCCTTGTCGTGCATTGTAAAAGGGCTCAGTGTTACTGGTTACAGGGAAGACTGAAGCTTTCACCCTGACATTCTGAAATGTCAACCGAAACTCTCCTTCCTCCTGTAAAGGACCTTGATGGGGCAGATTCCATTGATCAAAGAATGGGGACTTGTCACCTATACAATGGTACGTGACAGAACTTTGAGGTGGACTGCATTTAATAATAGTCACAATGTTAAAAGAACAAAATTCTTGAGCAGTTTTTTTTTTTTGTTTTGTTTTGTTTTCAAAAAATGTTCAGGTTTATTTGTGGAAATGCAAGATTTCTATAAAATAGTTTTTGTATGGAAATTTTTGTAATACTTTTTATCAACAAAATAAGAACACATGTTTCTGTCAGGGGTGTGAGGTCAAGCATGAACGGTAGTGCGTGTGCACCACCAACGTTTGGTGAAACTATTTTTATCAAGAAAAAGGAATCATAGAAGAGAAATATTTTCAAGTTAGATACTATAAAAGCTAGGTGCACTACCACCACGGCTTGTCGCGCCACACCCCTGAGTCCACAAGGTGGATAACATATTGTAATGAACAGTTGTGTGTAAAATGGCAAAAGACACAGACCTCTTGACAACATTGTGAAAACAGTTGAGTGCACACAGTTTGCTGTTTGAATCCAATGCACAAAAATTTTACAAAAATCCATTAAAATTATGTCCGTTTTAAAAC</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Piriform cortex</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Olfactory lobe</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Caudate-putamen</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Hippocampus</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Granular cell layer of the cerebellum</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Dentate gyrus</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Postsynaptic cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>Grik2</Gene_Name>
    <Gene_Alias>Glur6</Gene_Alias>
    <Gene_ID>54257</Gene_ID>
    <Genbank_ACCN>NM_019309</Genbank_ACCN>
    <Protein_ACCN>NP_062182</Protein_ACCN>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/54257</Gene_URL>
  </Gene>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 amino terminal domain dimer assembly MPD form</PDB_Title>
      <PDB_ID>3H6H</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3H6H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N-ACETYL-D-GLUCOSAMINE</Ligand_Name>
      <PubMed_Title>The N-terminal domain of GluR7-subtype glutamate receptor ion channels.</PubMed_Title>
      <Author>Kumar J</Author>
      <Journal>Nat Struct Mol Biol. 2009 Jun;16(6):631-8. Epub 2009 May 25.</Journal>
      <PubMed_ID>17115051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding domain dimer I442H K494E I749L Q753K mutant with glutamate and NaCl at 1.37 Angstrom resolution</PDB_Title>
      <PDB_ID>3G3I</PDB_ID>
      <Resolution>1.37</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3G3I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Stability of ligand-binding domain dimer assembly controls kainate receptor desensitization.</PubMed_Title>
      <Author>Chaudhry C</Author>
      <Journal>EMBO J. 2009 May 20;28(10):1518-30. Epub 2009 Apr 5.</Journal>
      <PubMed_ID>17115051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding domain dimer K665R I749L Q753K mutant with glutamate and NaCl at 1.5 Angstrom resolution</PDB_Title>
      <PDB_ID>3G3H</PDB_ID>
      <Resolution>1.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3G3H</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Stability of ligand-binding domain dimer assembly controls kainate receptor desensitization.</PubMed_Title>
      <Author>Chaudhry C</Author>
      <Journal>EMBO J. 2009 May 20;28(10):1518-30. Epub 2009 Apr 4.</Journal>
      <PubMed_ID>17115051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding domain dimer with glutamate and NaCl at 1.38 Angstrom resolution</PDB_Title>
      <PDB_ID>3G3F</PDB_ID>
      <Resolution>1.38</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3G3F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID$ISOPROPYL ALCOHOL</Ligand_Name>
      <PubMed_Title>Stability of ligand-binding domain dimer assembly controls kainate receptor desensitization.</PubMed_Title>
      <Author>Chaudhry C</Author>
      <Journal>EMBO J. 2009 May 20;28(10):1518-30. Epub 2009 Apr 2.</Journal>
      <PubMed_ID>17115051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding core ELKQ mutant dimer at 1.96 Angstroms Resolution</PDB_Title>
      <PDB_ID>2I0B</PDB_ID>
      <Resolution>1.96</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2I0B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Conformational restriction blocks glutamate receptor desensitization.</PubMed_Title>
      <Author>Weston MC</Author>
      <Journal>Nat Struct Mol Biol. 2006 Dec;13(12):1120-7. Epub 2006 Nov 19.</Journal>
      <PubMed_ID>17115050</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structure of the Kainate Receptor Subunit GluR6 Agonist Binding Domain Complexed with Domoic Acid</PDB_Title>
      <PDB_ID>1YAE</PDB_ID>
      <Resolution>3.11</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1YAE</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(2S,3S,4S)-2-CARBOXY-4-[(1Z,3E,5R)-5-CARBOXY- 1-METHYL-1,3-HEXADIENYL]-3-PYRROLIDINEACETIC ACID$ALPHA-L-FUCOSE$N-ACETYL-D-GLUCOSAMINE</Ligand_Name>
      <PubMed_Title>Structure of the kainate receptor subunit GluR6 agonist-binding domain complexed with domoic acid.</PubMed_Title>
      <Author>Namao MH</Author>
      <Journal>Proc Natl Acad Sci USA.2005 Feb 1;102(5):1708-13. Epub 2005 Jan 26.</Journal>
      <PubMed_ID>15677325</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>X-ray structure of the GluR6 ligand binding core (S1S2A) in complex with glutamate at 1.65 A resolution</PDB_Title>
      <PDB_ID>1S50</PDB_ID>
      <Resolution>1.65</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1S50</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.</PubMed_Title>
      <Author>Mayer ML</Author>
      <Journal>Neuron. 2005 Feb 17;45(4):539-52.</Journal>
      <PubMed_ID>15721240</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding domain dimer K665R mutant with glutamate and NaCl at 1.3 Angstrom resolution</PDB_Title>
      <PDB_ID>3G3G</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3G3G</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Stability of ligand-binding domain dimer assembly controls kainate receptor desensitization.</PubMed_Title>
      <Author>Chaudhry C</Author>
      <Journal>EMBO J. 2009 May 20;28(10):1518-30. Epub 2009 Apr 3.</Journal>
      <PubMed_ID>17115051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of GluR5 ligand-binding core in complex with sodium at 1.72 Angstrom resolution</PDB_Title>
      <PDB_ID>3C32</PDB_ID>
      <Resolution>1.72</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3C32</PDB_URL>
      <Has_Ligand>Yes</Has_Ligand>
      <ASD_Ligand>ASD03160008;ASD01630003</ASD_Ligand>
      <PubMed_Title>Molecular basis of kainate receptor modulation by sodium.</PubMed_Title>
      <Author>Plested, A.J., et al.</Author>
      <Journal>Neuron(2008)58:720-735</Journal>
      <PubMed_ID>18549784</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GLUR6 ligand binding core in complex with quisqualate at 1.8A resolution</PDB_Title>
      <PDB_ID>1S9T</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1S52</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>(S)-2-AMINO-3-(3,5-DIOXO-[1,2,4]OXADIAZOLIDIN- 2-YL)-PROPIONIC ACID</Ligand_Name>
      <PubMed_Title>Crystal structure of the GluR6 ligand binding core in complex with glutamate at 1.76 A resolution orthorhombic form</PubMed_Title>
      <Author>Mayer ML</Author>
      <Journal>Neuron. 2005 Feb 17;45(4):539-54.</Journal>
      <PubMed_ID>15721240</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding domain dimer I442H K494E K665R I749L Q753K mutant with glutamate and NaCl at 1.32 Angstrom resolution</PDB_Title>
      <PDB_ID>3G3J</PDB_ID>
      <Resolution>1.32</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3G3J</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Stability of ligand-binding domain dimer assembly controls kainate receptor desensitization.</PubMed_Title>
      <Author>Chaudhry C</Author>
      <Journal>EMBO J. 2009 May 20;28(10):1518-30. Epub 2009 Apr 6.</Journal>
      <PubMed_ID>17115051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 amino terminal domain dimer assembly</PDB_Title>
      <PDB_ID>3H6G</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3H6G</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>N-ACETYL-D-GLUCOSAMINE$L(+)-TARTARIC ACID</Ligand_Name>
      <PubMed_Title>The N-terminal domain of GluR6-subtype glutamate receptor ion channels.</PubMed_Title>
      <Author>Kumar J</Author>
      <Journal>Nat Struct Mol Biol. 2009 Jun;16(6):631-8. Epub 2009 May 24.</Journal>
      <PubMed_ID>17115051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity</PDB_Title>
      <PDB_ID>1SD3</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1S53</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>2S,4R-4-METHYLGLUTAMATE</Ligand_Name>
      <PubMed_Title>Crystal structure of the GluR6 ligand binding core in complex with glutamate at 1.77 A resolution orthorhombic form</PubMed_Title>
      <Author>Mayer ML</Author>
      <Journal>Neuron. 2005 Feb 17;45(4):539-55.</Journal>
      <PubMed_ID>15721240</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding core in complex with glutamate at 1.75 A resolution orthorhombic form</PDB_Title>
      <PDB_ID>1S7Y</PDB_ID>
      <Resolution>1.75</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1S51</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Crystal structure of the GluR6 ligand binding core in complex with glutamate at 1.75 A resolution orthorhombic form</PubMed_Title>
      <Author>Mayer ML</Author>
      <Journal>Neuron. 2005 Feb 17;45(4):539-53.</Journal>
      <PubMed_ID>15721240</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF THE GLUR6 LIGAND BINDING CORE IN COMPLEX WITH KAINATE 1.93 A RESOLUTION</PDB_Title>
      <PDB_ID>1TT1</PDB_ID>
      <Resolution>1.93</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=1S54</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>3-(CARBOXYMETHYL)-4-ISOPROPENYLPROLINE</Ligand_Name>
      <PubMed_Title>Crystal structure of the GluR6 ligand binding core in complex with glutamate at 1.78 A resolution orthorhombic form</PubMed_Title>
      <Author>Mayer ML</Author>
      <Journal>Neuron. 2005 Feb 17;45(4):539-56.</Journal>
      <PubMed_ID>15721240</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding domain dimer I442H K494E K665R I749L Q753K E757Q mutant with glutamate and NaCl at 1.24 Angstrom resolution</PDB_Title>
      <PDB_ID>3G3K</PDB_ID>
      <Resolution>1.24</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=3G3K</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID$ISOPROPYL ALCOHOL</Ligand_Name>
      <PubMed_Title>Stability of ligand-binding domain dimer assembly controls kainate receptor desensitization.</PubMed_Title>
      <Author>Chaudhry C</Author>
      <Journal>EMBO J. 2009 May 20;28(10):1518-30. Epub 2009 Apr 7.</Journal>
      <PubMed_ID>17115051</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal structure of the GluR6 ligand binding core dimer crosslinked by disulfide bonds between Y490C and L752C at 2.25 Angstroms Resolution</PDB_Title>
      <PDB_ID>2I0C</PDB_ID>
      <Resolution>2.25</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?pdbId=2I0C</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <Ligand_Name>GLUTAMIC ACID</Ligand_Name>
      <PubMed_Title>Conformational restriction blocks glutamate receptor desensitization.</PubMed_Title>
      <Author>Weston MC</Author>
      <Journal>Nat Struct Mol Biol. 2006 Dec;13(12):1120-7. Epub 2006 Nov 20.</Journal>
      <PubMed_ID>17115050</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04724</Pathway_ID>
      <Pathway_Title>Glutamatergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04724</Pathway_ID>
      <Pathway_Title>Glutamatergic synapse</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a/b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.d.beb.b.b.dc.html</SCOP_URL>
    <CATH_Class>Mixed alpha-beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1s50</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,737,Met;site,511,Asp</Site_Detail>
      <Site_Reference>Plested AJ, et al. Neuropharmacology. 2009,56(1):114-120.</Site_Reference>
      <PDB_ID>3G3F;3G3G;3G3H;3G3I;3G3J;3G3K;3H6G;3H6H</PDB_ID>
      <PubMed_ID>18687343</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00170297</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00240007</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00240009</ASD_ID>
      <Modulator_Feature>Activator</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730004</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730005</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730006</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730007</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730008</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730009</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730010</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730011</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730012</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730013</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730014</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730015</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730016</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730017</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730018</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730019</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730020</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730021</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730022</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730023</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730024</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730025</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730026</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730028</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730029</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730030</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730031</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730032</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730033</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730034</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730035</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730036</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730037</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730038</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730039</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730040</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730041</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730042</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730043</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730044</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730045</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730046</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730047</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730048</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730049</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730050</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730051</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730052</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730053</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730054</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730055</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730056</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730057</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730058</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730061</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730062</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730075</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730076</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730077</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730078</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730079</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730080</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730081</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730092</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730093</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730094</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730095</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730096</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD01730102</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>